Guideline for optimization of colorectal cancer surgery and pathology.
about
Assessment of lymph node involvement in colorectal cancerQuality indicators of clinical cancer care (QC3) in colorectal cancerThe Need for Consensus and Transparency in Assessing Population-Based Rates of Positive Circumferential Radial Margins in Rectal Cancer: Data from Consecutive Cases in a Large Region of Ontario, Canada.Impact of multimodal therapy in locally recurrent rectal cancerInternational preoperative rectal cancer management: staging, neoadjuvant treatment, and impact of multidisciplinary teams.Physician level reporting of surgical and pathology performance indicators: a regional study to assess feasibility and impact on qualityWhen is good, good enough? Methodological pragmatism for sustainable guideline development.QuickSilver: A Phase II Study Using Magnetic Resonance Imaging Criteria to Identify "Good Prognosis" Rectal Cancer Patients Eligible for Primary SurgeryThe effect of preoperative chemoradiotherapy on lymph nodes harvested in TME for rectal cancer.Meta-analysis of histopathological features of primary colorectal cancers that predict lymph node metastases.Extended lymphadenectomy in colon cancer is debatable.A descriptive analysis of gastric cancer specimen processing techniques.Population-Level Differences in Rectal Cancer Survival in Uninsured Patients Are Partially Explained by Differences in Treatment.Methylene blue-assisted lymph node dissection technique is not associated with an increased detection of lymph node metastases in colorectal cancer.Risk factors associated with poor lymph node harvest after colon cancer surgery in a national cohort.The role of adjuvant chemotherapy in stage II colorectal cancer patients.Prognostic impact of the length of the longitudinal resection margin in colon cancer.
P2860
Q26750245-5B29413C-64BE-4385-B4FA-098B3D1115ABQ28676969-280FF4A1-3340-49BA-82B4-FBEF3C1A9743Q31006026-784244CF-24A9-43BD-B0FE-129C763B5C68Q33609932-90DF6C5A-0096-49E8-92C6-1725EA1EA61CQ34173100-911DF07A-8684-478A-87AA-FA7ADAB007E3Q35024180-3F426419-869F-437E-90EE-5E5975DD06A3Q35176672-D188924F-8E09-4671-9948-6021CEBEE785Q35548001-83005E3B-00C3-406F-9185-65517402C955Q37427804-72D2CEE6-18F8-4DB1-B85A-2D1575AD543BQ37977032-348E7C64-58DE-4CAD-AE2F-AB75827A267BQ38104895-AEC74ED4-E520-45AD-9C9A-C6E8A1AF240EQ38424680-0159CD69-E598-4ED0-81A2-D5041E5639FDQ38951146-EB046500-A192-4541-9C7D-DE20D5DBEC59Q44814903-426120FE-5A95-4284-A38C-FBD2F9F5F818Q46497322-F85A259E-E440-4110-AF98-83DAEB4D4F63Q48254485-0AC36842-C99E-49D2-8340-AD1D95244310Q54128028-0F0E8A58-9594-43B4-A6E5-15350C0F672C
P2860
Guideline for optimization of colorectal cancer surgery and pathology.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Guideline for optimization of colorectal cancer surgery and pathology.
@en
Guideline for optimization of colorectal cancer surgery and pathology.
@nl
type
label
Guideline for optimization of colorectal cancer surgery and pathology.
@en
Guideline for optimization of colorectal cancer surgery and pathology.
@nl
prefLabel
Guideline for optimization of colorectal cancer surgery and pathology.
@en
Guideline for optimization of colorectal cancer surgery and pathology.
@nl
P2093
P356
P1476
Guideline for optimization of colorectal cancer surgery and pathology.
@en
P2093
Amber Hunter
Andrew J Smith
Bernard Langer
David K Driman
Expert Panel on Colon and Rectal Cancer Surgery and Pathology
Karen Spithoff
Marko Simunovic
Robin S McLeod
P356
10.1002/JSO.21395
P577
2010-01-01T00:00:00Z